Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...

Brianne Gardner's 2025 stock picks

As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...

In conversation with: Pierre Gratton: How can we built more mines faster in Canada?

The Mining Association of Canada’s President and CEO Pierre Gratton discusses his Vancouver Board of Trade presentation addressing the question, “How can we build more mines faster? He covers several key issues including, the need for critical miner...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

Rick Rule's holiday gifts to grow wealth

The average Canadian will spend C$1478 this holiday season with 43 per cent of the budget spent with online platforms Rule likes the idea of gifting precious metals and company shares as an alternative to traditional Christmas gifts “Philanthropy with a...

From now on, dynaCERT instead of Bitcoin or NVIDIA?

While Bitcoin and NVIDIA dominate the headlines and investors hope for the next rally, a promising opportunity is emerging with dynaCERT Inc. (ISIN: CA26780A1084 | Ticker-TSX: DYA) for those seeking a true growth story. Read on to learn why this Canadian company may now b...

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

This past week, Canada’s main stock index, the TSX , hovered just shy of a new all-time high, buoyed by rising metal prices. However, the optimism was tempered as markets stuttered in response to renewed fears surrounding geopolitical tensions, particular...

Unique Battery Metals opportunity in Quebec

Coniagas Battery Metals Inc (TSXV:V.COS ), a Canadian Junior Mining Company focused on nickel, copper, cobalt and platinum group metals in Quebec. The Market Online recently sat down again with CEO and Director, Frank Basa The following is a transcription of the abo...

Eminent Gold: Driving world class gold discoveries in Nevada

Eminent Gold Corp (TSXV:EMNT) is a Nevada focused gold exploration company pursuing world-class gold discoveries using new concepts and modern exploration methods. The Market online recently sat down with CEO and Director, Paul Sun. The following is a transcription...
1 2 3 4 5 6 7 8 9 10 ...